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We simulate a two-dimensional, lattice based, protein-level statistical mechanical model for prion
diseases (e.g., Mad Cow disease) with concommitant prion protein misfolding and aggregation. Our
simulations lead us to the hypothesis that the observed broad incubation time distribution in epi-
demiological data reflect fluctuation dominated growth seeded by a few nanometer scale aggregates,
while much narrower incubation time distributions for innoculated lab animals arise from statistical
self averaging. We model ‘species barriers’ to prion infection and assess a related treatment protocol.
PACS Indices: 82.30.-k, 82.35.Pq, 87.15.Cc
Transmissible neurodegenerative prion diseases, such
as Mad-Cow Disease (BSE) and Creutzfeldt-Jakob Dis-
ease (CJD) in humans, increasingly represent a serious
public health threat [1]. Prusiner and collaborators have
shown that the infectious agent (prion) in these diseases
consists of a quantity of a misfolded form (PrPSc) of the
∼200 amino acid PrPC protein which is expressed ubiq-
uitously in mammalian neurons [2]. The PrPC proteins
normally reside on neuron surfaces [4], and the more hy-
drophobic PrPSc forms tend to aggregate: large (micron
scale) PrPSc amyloid plaques are a common post-mortem
feature of brain tissues, and fibrils are observed in in vitro
experiments. Nucleic acid free propagation demands that
PrPSc autocatalyze their own formation by helping to
convert more PrPc into PrPSc [2,3]. Given that mam-
malian PrPc differ by only 5-10% in amino acid composi-
tion and that variant CJD correlated with BSE has been
observed in England, the efficacy of “species barriers” in
limiting transmission is of considerable interest.
Several facts suggest that prion disease may be driven
less by complex biology (as in Alzheimers’ disease) than
by physico-chemical processes, including: (1) The “uni-
versal character” of sporadic CJD, observed globally
without evident spatio-temporal clustering at an annual
background death rate of 0.5-1.5/million and mean onset
age of about 63 years [6]. (2) Highly reproducible incu-
bation time vs. infectious dose distributions observed in
laboratory animal studies, with a power law relation be-
tween mean incubation time and dose concentration D
[7]. (3) The close temporal proximity of disease onset
and death. (4) PrPSc may be grown in vitro without
biological processing and is toxic to neurons, though not
yet demonstrably infectious [5]. The following question is
thus raised: is the incubation time of prion disease dom-
inated by a fundamental physico-chemical nucleation and
growth of PrPSc protein aggregates?
We present simulation results for a simple two-
dimensional, lattice based statistical mechanical model
for prion disease based at the protein level. It is all but
hopeless to develop an atomic level simulation capable of
spanning the 21 temporal orders of magnitude between
picosecond scale intra-protein motion and the potentially
decades long incubation times of large prion aggregates.
Our simulation is a bridge between the short distance
and time scales covered in individual protein models and
the long time, macroscopic realm of chemical kinetics.
We use our simulations to identify the protectorate of
principles necessary to describe the aforementioned uni-
versal features of prion disease. Specifically, we find: (1)
Concommitant PrPSc autocatalysis and stable aggrega-
tion can explain the long disease incubation times, and
the difference between sporadic (unseeded) and infectious
(seeded) onset. This principle is consistent with data for
yeast prions [10], is closely related to the earlier nucle-
ation theory of Lansbury [8], and avoids the need to fine
tune model parameters with separated autocatalysis and
aggregation [9]. (2) The distributions of disease incu-
bation times (well defined onset edge, broad fluctuation
driven spectrum for dilute prion doses, narrow short time
shifted distribution for more concentrated prion doses)
stongly suggest a central role for growth from a minimally
nanometer scale seed (with order 10 PrPSc proteins).
With these assumptions we obtain a one parameter fit
to the BSE incubation time data, an order of magnitude
correct estimate of the mean incubation time for BSE and
infectious CJD, and we argue that self-averaging explains
a narrowing of incubation time distributions observed in
the laboratory [7,11]. Finally, by considering both stick-
ing and interconversion rate differences for prions of dif-
ferent species, we provide a theoretical underpinning to
data for the species barrier efficacy and to proposed treat-
ments based upon coating of incipient prion plaques.
Our assumption of two-dimensionality is consistent
with the observation that PrPc resides on neuron surfaces
and autocatalysis and aggregation must certainly initiate
there. The lattice structure should be irrelevant at long
times. By assuming a triangular lattice we minimize the
anisotropy (which appears first in rank six tensors for
hexagonal lattices). This simulation yields the crucial
qualitative features necessary to specify the “prion pro-
tectorate.” Our resulting prion aggregates are essentially
amorphous, rather than quasi-one-dimensional filaments
as found in some in vitro experiments. We shall discuss
an anisotropic simulation yielding fibrils elsewhere.
1
Our model is based upon the energy landscape schema-
tized in Fig. 1. Individual lattice cells take on three val-
ues: unoccupied (implicitly filled with water), occupied
by a PrPc protein, or occupied by a PrPSc protein. At
the beginning of each simulation, we choose a monomer
PrPc configuration distributed randomly, with a number
(0-4) of PrPSc seeds located randomly as well.
In the spirit of cellular and molecular automata, we es-
chew an explicit Hamiltonian based molecular dynamics
in favor of the following updating rules, specified in time
units of one full lattice sweep (d is the nearest neighbor
coordination number):
(1) Identify each occupied cell as PrPC or PrPSc by
checking its number of nearest neighbors.
(2) For each PrPC , move one step in a random di-
rection if that adjoining site is unoccupied.
(3) Identify aggregates (size NP ) by PrP
Sc presence;
move them per Rule (2) with probability 1/
√
Np.
(4) For d = 0, 1 the protein remains PrPC .
(5) For d = 2, the protein is PrPC or PrPSc with equal
probability
(6) For d ≥ 3 the protein is PrPSc.
Rules (1-3) ensure diffusive motion of PrPC monomers
and PrPSc aggregates. Rules (4-6) specify protein in-
teractions and autocatalysis, and reflect the relative hy-
drophobicity of PrPSc. To assure the biologically plausi-
ble condition of constant average PrPC concentration, at
the start of a new sweep we randomly place a new PrPC
for each lost in the previous update.
This procedure is repeated for up to millions of full
sweeps through the lattice. Note that a sweep defines
the minimum time scale for conversion of PrPC to PrPSc,
which is presumably of order a second or less in real time.
We work with maximum lattice sizes of N = 4 × 104.
Practically, we are able to run at areal monomer con-
centrations c ≥ 0.1%, which are likely to be about three
orders of magnitude larger than in the brain.
We run our seeded simulations repeatedly following
the largest nano-aggregates until they reach a size of up
to 0.4% of the lattice. Each seed consists of 10 PrPSc
monomers [12] For a given aggregate size, we have stud-
ied the properties of the distribution of lifetimes to reach
that size. For a final aggregate size of A=0.2%N (80
monomers) we display the corresponding distributions
PD in Fig. 2(a) for several values of c and D = 1. PD
displays greater fluctuations for small c, and increasing
c shifts PD to short times. Fluctuations dominate the
growth from the small seed aggregate. For larger A we
find that the onset time grows sublinearly in A, while
the distribution width grows weakly with A. To within
fluctuations, the PD curves for different c collapse when
scaled by the mean time tm. (The curves broaden some-
what for D = 2, 3, 4.) This implies the scaling law
PD(t, c) ≈ 1
tm(c)
FD(
t
tm(c)
) (1)
In the range of concentrations studied, we can fit tm(c)
well by either: (a) the polynomial form tm(c) ∼ Ac−1 +
Bc−2 (the first term reflecting monomer aggregation, the
second representing dimer aggregation), or (b) a power
law form, tm(c) ∼ c−α(D), with α(D) = 1.66(D =
1), 1.49(D = 2). For finite A and c → 0 the exponent
α(D) should tend to two, reflecting dominant dimer ag-
gregation. Fit (b) is consistent with a nontrivial scaling
limit as A → ∞, c → 0. Both fits to tm(c) give order
of magnitude equivalent extrapolations to lower c rele-
vant to biological contexts. Assuming tm(c) ∼ D−β at
fixed c, we estimate β ≤ 1 with large numerical uncer-
tainty. Taken together, these data lead us to a conjec-
ture of asymptotic compression of PD: for c → 0, an in-
creasingly large range of A will have essentially the same
scaled shape, because the time t2 it takes to go from A
to say, 2A will be much smaller than tm for going from
10→ A.
We believe that other processes, such as protease at-
tack or competition between PrPSc-PrPSc and PrPSc-
neuron binding will limit prion aggregation on the neu-
ral surface and cause fissioning and spreading of nano-
aggregates to other neurons. Such fission is necessary for
exponential growth of infectious agents, as noted previ-
ously [14]. At the order-of-magnitude level t2 sets the
doubling time for disease spread, assuming that inter-
cellular diffusion rates exceed intra-cellular ones. Given
t2 << tm (at biological c values) both in our fission hy-
pothesis and experiment, slow growth fluctuations for
small seed aggregates can dominate the overall incuba-
tion time for disease. For example, in hamster experi-
ments the first observable levels of PrPSc in brain tissues
occur at about 90 days, with symptom onset at 120 days,
and a doubling time of 2 days [13]. Given the conjec-
tured asymptotic compression, the incubation time dis-
tribution will be relatively insensitive to a wide range of
nano-aggregate sizes for fission parents or progeny.
We stress several points of agreement with observa-
tion and laboratory data. First, we always find death
(runaway growth of a killer aggregate) in the presence
of infection, in agreement with experiment and the ag-
gregate nucleation hypothesis for prion disease. Second,
our rough scaling of tm with D agrees qualitatively with
the extraordinarily reproducible dose vs. incubation time
data of Prusiner and collaborators for prion infection in
laboratory mice, for which τI ∼ D−.62. Third, our life-
times are in order of magnitude agreement with observed
BSE incubation times and new variant CJD death ages,
which we can prove by exploiting our concentration scal-
ing. For a single seed, at our lowest concentration of 0.1%
our distribution peaks at about 104 sweeps. Assuming a
literature estimate of concentration of in vivo prions in
solution of 100 nanomole/liter [15] and a protein diame-
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ter of order one nanometer suggests a dimensionless areal
concentration of about 10−3%. With the above concen-
tration scaling this gives an incubation time of about 108
sweeps. If we take the 5 year mean incubation time for
BSE this implies our basic misfolding time (one sweep)
is about one second, which is reasonable at the order
of magnitude level. Finally, by simply scaling time for
A = 80 by the mean time tm, we achieve an exceptionally
good fit (A) of the inferred incubation time distribution
for BSE in the United Kingdom (for cattle born in 1987)
[16] to our scaling curve as shown in Fig. 2(b). This
supports our hypothesis that runaway autocatalytic ag-
gregation seeded by a few prion nano-aggregates triggers
the disease. This is very plausible since (i) infection is
believed to have come from rendering plant offal derived
from many animals after considerable processing,leading
to substantial dilution, and (ii) prion transmission by
oral consumption is estimated to be less efficient than
innoculation by a factor of 109.
Sporadic CJD develops in the absence of any infec-
tion or genetic predisposition to prion disease. We have
studied the lifetime distributions in this case and find
that they are very different in shape than the seeded
runs, being much broader and dimer fluctuation domi-
nated (peaks scale as c−2). For our estimated biological
concentration of c = 10−3%, this could give a mean onset
time as large as 103 years. Assuming a constant height
tail from the minimum single seed onset to the mean hu-
man lifespan taken with the 1 part in 106 odds of dying
from sporadic CJD gives an estimate of a total death
probability of a part in 105 up to this mean on-set time.
This is consistent with our simulations, but not resolv-
able currently.
In contrast to the breadth of our single seed lifetime
distributions, in the event of dosing by a greater number
of seeds, self-averaging will narrow the distribution, col-
lapsing it towards the onset (shorter times). Assuming
growth proceeds independently for different seeds (which
is quite reasonable for the low concentrations in living or-
ganisms) distributions would narrow by
√
D. Several in
vivo experiments show distribution time narrowing with
increased doseage, but are not amenable to quantitative
analysis at this time [7,11].
We turn now to the species barrier. To simulate inter-
species transmission we replace the integer-valued coor-
dination, the key parameter which determined the stabil-
ity of different protein conformations in the earlier stud-
ies, by a new variable x = N + N ′ × P for PrPC and
x′ = N ′ +N × P ′, for PrPC′, where N is the number of
PrPC,Sc neighbors and N ′ the number of PrPC,Sc′ neigh-
bors. The parameters P and P ′ (chosen less than unity)
provide a measure of the reduced effectiveness of inter-
species conversion. To deal with the continuous variable
x, rather than the integer coordination used earlier, we
represent the PrPC to PrPSc conversion probability f(x)
by
f(x) =
1
eβ(x−2) + 1
(2)
with a similar definition for PrPC′ →PrPSc′ conversion.
A separate parameter describes physisorption to an ag-
gregate of alien prions. We allow a PrPC,Sc cluster of
mass M (M = 1 being a monomer) to desorb from an
alien prion aggregate with probability qK/
√
M , where
q is the physisorption parameter, and K is the number
of units in the cluster adjacent to the alien aggregate.
We define q′ for PrPC,Sc′ similarly. Thus, we describe
species barriers in terms of the two parameters affecting
conversion rates (P, P ′) and physisorption (q, q′). Mak-
ing P 6= P ′ and q 6= q′ allows for an asymmetry in infec-
tivity, and we can model one of the most striking aspects
of the species barrier, namely its asymmetry (e.g. mice
infect hamsters well, hamsters infect mice poorly).
We have carried out several simulations relevant to the
species barrier. First, we have placed alien prion ‘walls’
on a boundary, representing a single large aggregate from
another species. With suitable choice of parameters,
this leads to the asymmetric species barrier between two
species. Namely, disease onset in one species (with large
aggregates) and only sub-critical PrPSc concentration
near the wall in the other. Recent experimental data
has also shown the build up of such sub-critical PrPSc
concentration in the asymmetric interspecies transmis-
sion [17].
Second, suppose the asymmetry is such that P << P ′.
In this case, PrPSc′ is more favorably formed from PrPC′
in the presence of a seed aggregate of PrPSc than PrPSc
is formed from PrPC in the presence of a PrPSc′ seed.
Thus, by injecting a large enough initial dose of alien
PrPC′ proteins into the organism, it should be possible
for PrPC′ to compete favorably with PrPC for aggrega-
tion, and thus extend the incubation time. Such proto-
cols have been tested experimentally: (i) Experiments
with the coating dye molecule Congo Red [18] reveal
a surprising non-monotonic dose vs. lifetime relation:
small Congo Red concentrations yield a reduced time for
incubation, while larger Congo red concentrations signif-
icantly extend the incubation time. (ii) In vitro exper-
iments show that the above coating scenario with alien
prions works [19] when the initial PrPC′ concentration
c′ > c.
We find both of these experimental features in our sim-
ulation as shown in Fig. 3. For c′/c < 2, the incuba-
tion time is slightly shortened, while for c′/c > 2 the
incubation time is increased. We find that the lifetime
shortening arises because once a few PrPC′ aggregate,
they partially block the motion of adjacent PrPC pro-
teins, enhancing the misfolding probability of the latter.
However, further PrPC misfolding is significantly reduced
once PrPSc′ coats the seed.
A crucial test of our theory would be to monitor, in
vitro, the lifetime distributions of normal prion proteins
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seeded by small aggregates as a function of both c and
D to look for the scaling behavior. If it is not possible
to easily achieve D = 1, 2, presumably the distribution
of Fig. 2(b) could be estimated by extrapolation from
successively diluted PrPSc doses. This would also test
the extent to which the self-averaging applies. If our
single seed hypothesis is correct, it is important to assess
how passage occurs upon infection.
Theoretically, it is important to extend our model by
including internal degrees of freedom for the proteins
which can provide an orientational dependence to the ag-
gregation, allowing for linear fibril formation as opposed
to amorphous aggregates. This connects naturally with
simulations on individual proteins, and also allows for
the study of different protectorates for collective protein
phenomena.
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FIG. 1. Schematic energy landscapes for model prion pro-
teins. Upper figures show proteins in varying coordination
environments corresponding to rules (1-6), lower figures show
schematic energy landscapes.
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FIG. 2. Aggregation lifetime distributions PD(t, c) for a
single seed (D=1). Seeds have ten proteins, simulations ter-
minate at aggregate size A = 80, time is measured in units
of 104 full lattice sweeps. (a) Dependence upon areal con-
centration c of normal prion proteins. (b) Scaled distribu-
tion F1(t/tm) vs. t/tm. tm is the mean lifetime for a given
concentration. Points are inferred incubation time data for
BSE-infected cattle in the United Kingdom born in 1987.
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FIG. 3. Mean incubation time tm vs. relative concentra-
tion of alien prions c′/c (test of coating treatment; see text
for discussion).
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